初创公司Generation Lab宣布研发出一种名为"1 Generation"的抗衰老注射药物，由两种现有药物组合而成，声称能够阻止血液中的衰老传播并激活身体修复机制1。该公司首席执行官Alina Su表示，"这是第一个在人体内有效的衰老逆转疗法"1。Generation Lab由长期从事血液年轻化研究的科学家Irina Conboy创立1，药物的具体成分目前保密1。
公司已在小范围内进行了测试，使用者包括26岁的CEO Su、Irina Conboy及其丈夫Michael Conboy1。使用者报告称获得了多项改善，包括一位64岁女性视力增强、一位59岁男性体力增强和握力改进、以及勃起功能改善等1。Generation Lab计划启动包含百余人的更大规模临床试验，该试验将由替代医学医生主导，包括BioReset Medical创始人Matt Cook1。公司还计划于8月28日举办邀请制活动，邀请包括哈佛合成生物学家George Church等业内专家参与讨论1。
在监管方面，Generation Lab将寻求美国FDA的新用途快速审批流程，该流程可获得约三年的排他性期限1。
Generation Lab, founded by longevity researcher Irina Conboy, has announced the development of an anti-aging injectable called "1 Generation," which the company says represents a breakthrough in reversing biological aging 1. The drug is composed of a combination of two existing medications and is designed to halt the circulation of aging factors in the bloodstream while activating the body's repair mechanisms 1.
The startup has already conducted limited testing with a small group of users, including CEO Alina Su, age 26, Irina Conboy, and her husband Michael Conboy 1. According to the company, early users have reported various improvements: a 64-year-old woman experienced better vision, while a 59-year-old man noted increased physical strength, improved grip strength, and enhanced erectile function 1. Su stated that this represents "the first aging reversal therapy that works in the human body" 1.
Generation Lab plans to launch a larger clinical trial involving over one hundred participants, to be led by alternative medicine physician Matt Cook, founder of BioReset Medical 1. The company intends to pursue the FDA's expedited approval pathway for new uses of existing drugs, which would grant approximately three years of exclusivity 1. Specific details about the drug's composition remain undisclosed 1. The company has also scheduled an invitation-only event for August 28th featuring speakers including Harvard synthetic biologist George Church 1.
评论
还没有评论，欢迎留下第一条。